. 2011 Jan 8;215(2):345–352. doi: 10.1007/s00213-010-2147-6

Table 1.

Prolactin concentrations (ng/ml) over the study period presented by phase and month in phase the measure was taken. Standard deviations are in parentheses. These data are published in Sackett et al. (2010)

	Pre-drug	Low-dose		Moderate-dose		Post-drug
	Month 3	Month 1	Month 3	Month 1	Month 3	Month 1
Placebo	10.2	10.1	9.9	10.1	9.7	9.1
Placebo	(5.9)	(6.2)	(6.7)	(6.3)	(7.4)	(5.8)
Risperidone	12.5	42.0^a	20.8^a	32.2^a	25.5^a	8.7^a
Risperidone	(4.9)	(16.6)	(8.8)	(14.2)	(7.6)	(4.3)
Quetiapine	12.5	10.3	6.6	6.4	9.4	9.7
Quetiapine	(7.6)	(6.3)	(2.5)	(2.2)	(4.5)	(4.1)

^aValues significantly different from the placebo group at each measurement